Syros Pharmaceuticals (NASDAQ:SYRS) Now Covered by StockNews.com
StockNews.com started coverage on shares of Syros Pharmaceuticals (NASDAQ:SYRS – Get Free Report) in a research note issued to investors on Sunday. The brokerage set a “sell” rating on the stock. SYRS has been the subject of several other research reports. Brookline Capital Management reaffirmed a “hold” rating on shares of Syros Pharmaceuticals in a […]
StockNews.com started coverage on shares of Syros Pharmaceuticals (NASDAQ:SYRS – Get Free Report) in a research note issued to investors on Sunday. The brokerage set a “sell” rating on the stock. SYRS has been the subject of several other research reports. Brookline Capital Management reaffirmed a “hold” rating on shares of Syros Pharmaceuticals in a […]
